Cargando…
A heparin binding synthetic peptide from human HIP / RPL29 fails to specifically differentiate between anticoagulantly active and inactive species of heparin
Despite extensive progress in determining structures within heparin and heparan sulfate (Hp/HS) and the discovery of numerous proteinaceous binding partners for Hp/HS so far; the only detailed characterization of a specific protein-glycosaminoglycan interaction is antithrombin III (ATIII) binding to...
Autores principales: | Hoke, David E, Carson, Daniel D, Höök, Magnus |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC152653/ https://www.ncbi.nlm.nih.gov/pubmed/12659638 http://dx.doi.org/10.1186/1477-5751-2-1 |
Ejemplares similares
-
Heparin or nonheparin anticoagulants for VITT
por: Arnold, Donald M.
Publicado: (2022) -
Engineered heparins as new anticoagulant drugs
por: Vaidyanathan, Deepika, et al.
Publicado: (2016) -
Non-Anticoagulant Heparins as Heparanase Inhibitors
por: Cassinelli, Giuseppe, et al.
Publicado: (2020) -
A meta-analysis of bridging anticoagulation between low molecular weight heparin and heparin
por: Tao, Ende, et al.
Publicado: (2020) -
Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole blood
por: Hogwood, John, et al.
Publicado: (2020)